Company / Free Cash Flow
Emergent BioSolutions Inc. Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$156.8M
FY2025
5-year range
-$257.9M / $156.8M
FY2021-FY2025
Trend
+338.0%
vs FY2024
Sector context
#38 of 194
Health Care
What the data says
Free Cash Flow changed +338% YoY in FY2025, a notable deviation from the 9-year average annual change of +178%.
Based on SEC 10-K filings.
$157M in FY2025 with a 5-year CAGR of -16.9%. Top quartile in the Health Care sector.
Improved from -$258M to $157M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -16.9%
- 10-Year CAGR
- -
Sector benchmark
Top 20% in Health CareTop 20% of 194This company $156.8M Sector average $470.6M
▼
-66.7% below sector average
Key checks
Key Insights
- 5-year CAGR of -16.9%, indicating a declining trend.
- In FY2025, free cash flow increased 338.0% year-over-year.
- Ranks #38 out of 194 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $156.8M | +338.0% |
| FY2024 | $35.8M | +113.9% |
| FY2023 | -$257.9M | -72.0% |
| FY2022 | -$149.9M | -256.0% |
| FY2021 | $96.1M | -75.7% |
| FY2020 | $395.0M | +290.7% |
| FY2019 | $101.1M | +568.1% |
| FY2018 | -$21.6M | -114.1% |
| FY2017 | $153.3M | +809.7% |
| FY2016 | -$21.6M | -841.2% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026